News
But it might not be long before a new option becomes available for anyone on a weight loss journey, thanks to a breakthrough ...
Rechelle never thought her body would let her down. She was 35, living in London with a dream job. She was even making plans ...
Now that the whole town is hooked on GLP-1 weight-loss drugs, surgeons are scrambling to tighten unsightly skin.
Novo Nordisk faces slowing demand, rising competition, and CEO transition. Learn about challenges impacting its growth and ...
Novo Nordisk fell by 21.83 percent on Tuesday to end at $53.94 apiece as investors unloaded positions following the company’s ...
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
Tack on a half-dozen zeros to your CVS receipt and you'll get a sense of the sticker shock afflicting state officials, insurers and hospitals dealing with the soaring cost of prescription drugs in ...
Cosmetic surgeons are reporting a growing number of patients with sagging skin and facial hollowing after losing weight with ...
Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...
Trump’s trade deal with the E.U. may lead to higher prices for brand-name drugs in the U.S., including Ozempic and Wegovy, ...
(Reuters) -Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than ...
Novo Nordisk A/S shares plunged after a Q2 revenue update and 2025 guidance downgrade. Click here to find out why NVO stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results